We Know the Origin of the Gold Bars Found at Bob Menendez's House
Is This the Owner of the Home That Exploded in Northern Virginia Last...
Democrats Embrace Mental Illness in the Name of Diversity
Vivek Ramaswamy Gets FBI Weaponization Very Wrong…Again
A Disappointing Non-Debate
New Harvard Youth Poll Is Out. Here's What It Shows for Biden, Trump.
RNC Announces Who Made the Stage for 4th GOP Debate
Here's What KJP Had to Say When Asked About Jayapal's Response to Hamas'...
Arizona, the Republican Party, and Its Discontents
Proposed Rule From Biden Administration Takes Aim at Pro-Life Pregnancy Centers
Kamala Harris Talks Climate As Houthis Attack US Navy Vessel
Dear 'Legacy Media,' the Calls of Authoritarianism are Coming from Inside the (White)...
The World Is Waking Up to the Consequences of Mass Migration. Will America?
Fact: Enlisted Troops Make Great Officers
Legal Hunting Reduces Deer Collisions and Should Be Encouraged

Stocks in the News: Priceline Rises as Short Positions Grow

The opinions expressed by columnists are their own and do not necessarily represent the views of Townhall.com.

Stocks in the News is produced by Ransom Notes Radio and Goodfellow, LLC. Crista Huff manages Goodfellow LLC, a website that recommends outperforming stocks using fundamental and technical analysis. 


Stock number one is: 

DaVita HealthCare Partners Inc., (SYMBOL: DVA) and the headline says:

Rebasing Continues a String of Negative Surprises for DaVita – Citi Research

Medicare announced that reimbursement rates for dialysis may fall significantly in 2014, alarming investors in DaVita HealthCare, the largest U.S. dialysis provider.  “Monday’s announced Medicare cut for dialysis services far surpasses our worst fears,” reports Citi Research.  Buy-side analysts were expecting an approximate 2% cut, but the net cut proposal came in at 9.4%.

Watch for DaVita's earnings estimates to fall towards a no-growth scenario in 2014.

Berkshire Hathaway owns 14% of DaVita stock, causing recent speculation of a buyout offer, which may provide some ongoing support for the stock price.  The chart is bearish, with support at $115.

Our Ransom Note trendline says:  STAY ON THE SIDELINES.

DVA Chart

DVA data by YCharts

Stock number two is: 

Apple Inc., (SYMBOL: AAPL) and the headline says:

Tech Stocks Signaling Sustained U.S. Growth -- Bloomberg

“Shares of technology companies are rallying as investors see capital spending for their products strengthening along with the economy,” reports Bloomberg.

Apple shares are rallying with news that the company filed with the Japan Patent Office in June to trademark the term "iWatch". The company is believed to be developing a digital wristwatch, which could provide new growth opportunities.


Apple’s earnings estimates are holding steady; projected to fall 10% this year.  With a PE of 10.3 and a dividend yield of 2.98%, there’s limited downside at this point.  The trading range is firming up between $385 and $465.

Our Ransom Note trendline says: APPLE IS A TRADING BUY UNDER $420.

AAPL Chart

AAPL data by YCharts

Stock number three is:

Priceline.com Inc., (SYMBOL: PCLN) and the headline says:

Priceline.com Becomes #26 Most Shorted Nasdaq 100 Component -- Forbes

Online travel company Priceline.com has been seeing increased recent short action.  Given its bullish chart, investors should expect any near-term breakout to be enhanced by short-covering.

Priceline recently issued $1 billion in senior notes at low interest rates, and intends to repurchase $1 billion in stock.  Earnings are projected to grow 21-23 percent per year over the next three years.

In February and May, we told investors to buy shares in Priceline.  The stock is up 21% since our first recommendation, and appears immediately ready to break past upside resistance at $845.

Our Ransom Note trendline says: BUY PRICELINE.COM

PCLN Chart

PCLN data by YCharts

Join the conversation as a VIP Member


Trending on Townhall Videos